1. Senolytics: Opening avenues in drug discovery to find novel therapeutics for Parkinson's Disease
- Author
-
Kakoty, V, Kalarikkal Chandran, S, Gulati, M, Goh, BH, Dua, K, and Kumar Singh, S
- Subjects
Medicinal & Biomolecular Chemistry ,0601 Biochemistry and Cell Biology, 1115 Pharmacology and Pharmaceutical Sciences - Abstract
Aging is one of the major risk factors for most neurodegenerative disorders including Parkinson's disease (PD). More than 10 million people are affected with PD worldwide. One of the predominant factors accountable for progression of PD pathology could be enhanced accumulation of senescent cells in the brain with the progress of age. Recent investigations have highlighted that senescent cells can ignite PD pathology via increased oxidative stress and neuroinflammation. Senolytics are agents that kill senescent cells. This review mainly focuses on understanding the pathological connection between senescence and PD, with emphasis on some of the recent advances made in the area of senolytics and their evolution to potential clinical candidates for future pharmaceuticals against PD.
- Published
- 2023